Global X Genomics & Biotechnology ETF
GNOM
68 hedge funds and large institutions have $30.1M invested in Global X Genomics & Biotechnology ETF in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 9 closing their positions.
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
6% more funds holding
Funds holding: 64 → 68 (+4)
0.65% more ownership
Funds ownership: 10.48% → 11.13% (+0.65%)
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
14% less capital invested
Capital invested by funds: $35.2M → $30.1M (-$5.03M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$622K |
| 2 |
Two Sigma Investments
New York
|
+$383K |
| 3 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$242K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$160K |
| 5 |
EWM
Executive Wealth Management
Brighton,
Michigan
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lido Advisors
Los Angeles,
California
|
-$1.51M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$579K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$363K |
| 4 |
Rockefeller Capital Management
New York
|
-$205K |
| 5 |
KF
Krilogy Financial
St. Louis,
Missouri
|
-$164K |
GNOM Hedge Fund Activity: Q4 2024 in Review
68 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2024, worth a combined $30.1M — down 14% from $35.2M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new GNOM positions and 9 closed out — a net gain of 5 holders — while 19 added to existing stakes and 20 trimmed.
The largest buyer was Flow Traders U.S., adding an estimated $622K. The largest seller was Lido Advisors, exiting entirely with an estimated $1.51M sold.
- 68 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2024, up from 64 in Q3 2024.
- Funds reported $30.1M of Global X Genomics & Biotechnology ETF stock for Q4 2024, down 14% quarter-over-quarter.
- 14 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2024 and 9 closed out, a net change of +5 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q4 2024 was Flow Traders U.S., an estimated $622K added.
- The largest Global X Genomics & Biotechnology ETF seller in Q4 2024 was Lido Advisors, an estimated $1.51M sold.
Based on aggregated 13F filings for Q4 2024.